These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9563068)

  • 1. The duration of measuring partial AUCs for the assessment of bioequivalence.
    Endrenyi L; Csizmadia F; Tothfalusi L; Balch AH; Chen ML
    Pharm Res; 1998 Mar; 15(3):399-404. PubMed ID: 9563068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metrics comparing simulated early concentration profiles for the determination of bioequivalence.
    Endrenyi L; Csizmadia F; Tothfalusi L; Chen ML
    Pharm Res; 1998 Aug; 15(8):1292-9. PubMed ID: 9706064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.
    Endrenyi L; Tothfalusi L
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Duquesnoy C; Lacey LF; Keene ON; Bye A
    Eur J Pharm Sci; 1998 Oct; 6(4):259-64. PubMed ID: 9795077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.
    Ring A; Tothfalusi L; Endrenyi L; Weiss M
    Pharm Res; 2000 May; 17(5):583-8. PubMed ID: 10888310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive and specific determination of the equivalence of absorption rates.
    Endrenyi L; Al-Shaikh P
    Pharm Res; 1995 Dec; 12(12):1856-64. PubMed ID: 8786956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Lacey LF; Keene ON; Duquesnoy C; Bye A
    J Pharm Sci; 1994 Feb; 83(2):212-5. PubMed ID: 8169791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY; Yoon H; Park GK; Lee YB
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.
    Gaudreault J; Potvin D; Lavigne J; Lalonde RL
    Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
    el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
    Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric.
    Kharidia J; Jackson AJ; Ouderkirk LA
    Pharm Res; 1999 Jan; 16(1):130-4. PubMed ID: 9950291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence evaluation of sparse sampling pharmacokinetics data using bootstrap resampling method.
    Shen M; Machado SG
    J Biopharm Stat; 2017; 27(2):257-264. PubMed ID: 27906608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria.
    Shram MJ; Quinn AM; Chen N; Faulknor J; Luong D; Sellers EM; Endrenyi L
    Clin Ther; 2012 May; 34(5):1170-81. PubMed ID: 22512898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metrics for the evaluation of bioequivalence of modified-release formulations.
    Endrenyi L; Tothfalusi L
    AAPS J; 2012 Dec; 14(4):813-9. PubMed ID: 22910857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy].
    Ding JJ; Jiao Z; Li ZD; Shi XJ
    Yao Xue Xue Bao; 2006 Sep; 41(9):893-8. PubMed ID: 17111840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power Analysis and Sample Size Determination for Crossover Trials with Application to Bioequivalence Assessment of Topical Ophthalmic Drugs Using Serial Sampling Pharmacokinetic Data.
    Yu YP; Yan XY; Yao C; Xia JL
    Biomed Environ Sci; 2019 Aug; 32(8):614-623. PubMed ID: 31488237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.